17th Expert Committee: Expert reviews
-
Amantadine and rimantadine (Inclusion) -- Reviewer 1
pdf, 126kb -
Amantadine and rimantadine (Inclusion) -- Reviewer 2
pdf, 141kb -
Amiodarone (Inclusion) -- Reviewer 1
pdf, 116kb -
Amiodarone (Inclusion) -- Reviewer 2
pdf, 76kb -
Antiemetic medicines (Inclusion) (Paediatrics) -- Reviewer 1
pdf, 124kb -
Antiemetic medicines (Inclusion) (Paediatrics) -- Reviewer 2
pdf, 124kb -
Antipsychotic and antidepressive medicines (Inclusion) -- Reviewer 1
pdf, 85kb -
Antipsychotic and antidepressive medicines (Inclusion) -- Reviewer 2
pdf, 66kb -
Antituberculosis medicines (Inclusion) (Paediatrics) -- Reviewer 1
pdf, 23kb -
Artemether + lumefantrine (Inclusion) (Paediatrics) -- Reviewer 1
pdf, 14kb -
Artemether + lumefantrine (Inclusion) (Paediatrics) -- Reviewer 2
pdf, 104kb -
Atazanavir (Inclusion) -- Reviewer 1
pdf, 200kb -
Atazanavir (Inclusion) -- Reviewer 2 (Late paper)
pdf, 106kb -
Beclometasone (New formulation) -- Reviewer 1
pdf, 150kb -
Beclometasone (New formulation) -- Reviewer 2
pdf, 121kb -
Captopril (Inclusion) (Paediatrics) -- Reviewer 1
pdf, 120kb -
Captopril (Inclusion) (Paediatrics) -- Reviewer 2
pdf, 158kb -
Carboplatin (Inclusion) -- Reviewer 1
pdf, 160kb -
Carvedilol (Inclusion) (Paediatrics) -- Reviewer 1
pdf, 53kb -
Carvedilol (Inclusion) (Paediatrics) -- Reviewer 2
pdf, 128kb -
Cromoglicic acid (Re-instatement) -- Reviewer 1
pdf, 137kb -
Cromoglicic acid (Re-instatement) -- Reviewer 2
pdf, 114kb -
Endar (Inclusion) -- Reviewer 1 (Late paper)
pdf, 100kb -
Endar (Inclusion) -- Reviewer 2
pdf, 116kb -
Escitalopram oxalate (Inclusion) -- Reviewer 1
pdf, 119kb -
Escitalopram oxalate (Inclusion) -- Reviewer 2
pdf, 57kb -
Hydroxycarbamide (Inclusion) -- Reviewer 1
pdf, 74kb -
Hydroxycarbamide (Inclusion) -- Reviewer 2
pdf, 112kb -
Hydrochlorothiazide (New formulations) -- Reviewer 2
pdf, 111kb -
Ibuprofen (Inclusion) (Paediatrics) -- Reviewer 1
pdf, 160kb -
Ibuprofen (Inclusion) (Paediatrics) -- Reviewer 2
pdf, 121kb -
Ifosfamide (Inclusion) -- Reviewer 1
pdf, 111kb -
Lamotrigine (Inclusion) -- Reviewer 1
pdf, 110kb -
Lamotrigine (Inclusion) -- Reviewer 2
pdf, 141kb -
Liposomal amphotericin B (Inclusion) (Paediatrics) -- Reviewer 1 (Late paper)
pdf, 82kb -
Lorazepam (Inclusion) -- Reviewer 1
pdf, 107kb -
Lorazepam (Inclusion) -- Reviewer 2
pdf, 119kb -
Mesna (Inclusion) -- Reviewer 2
pdf, 111kb -
Midazolam (Inclusion) -- Reviewer 1
pdf, 109kb -
Midazolam (Inclusion) -- Reviewer 2
pdf, 101kb -
Misoprostol (Inclusion) -- Reviewer 1
pdf, 508kb -
Misoprostol (Inclusion) -- Reviewer 2
pdf, 13kb -
Nicotine Replacement Therapy (NRT) (Inclusion) -- Reviewer 1
pdf, 132kb -
Nicotine Replacement Therapy (NRT) (Inclusion) -- Reviewer 2
pdf, 147kb -
Nifurtimox + eflornithine (Inclusion) -- Reviewer 1
pdf, 127kb -
Nifurtimox + eflornithine (Inclusion) -- Reviewer 2 (Late paper)
pdf, 90kb -
Omeprazole (Inclusion) -- Reviewer 1
pdf, 78kb -
Oseltamivir (Inclusion) -- Reviewer 1
pdf, 122kb -
Oseltamivir (Inclusion) -- Reviewer 2
pdf, 140kb -
Pralidoxime (Inclusion) -- Reviewer 1
pdf, 113kb -
Pralidoxime (Inclusion) -- Reviewer 2
pdf, 123kb -
Procaine benzylpenicillin (Review) (Paediatrics) -- Reviewer 1
pdf, 137kb -
Protease inhibitors (Review) -- Reviewer 1
pdf, 139kb -
Quinidine (Possible deletion) -- Reviewer 1
pdf, 45kb -
Quinidine (Possible deletion) -- Reviewer 2
pdf, 290kb -
Rifabutin (Inclusion) -- Reviewer 1
pdf, 109kb -
Sumatriptan (Inclusion) -- Reviewer 1
pdf, 115kb -
Sumatriptan (Inclusion) -- Reviewer 2
pdf, 104kb -
Tranexamic acid (Inclusion) -- Reviewer 1
pdf, 114kb -
Tranexamic acid (Inclusion) -- Reviewer 2
pdf, 76kb -
Zanamivir (Inclusion) -- Reviewer 1
pdf, 160kb -
Zanamivir (Inclusion) -- Reviewer 2
pdf, 141kb -
Zidovudine + lamivudine + abacavir (Inclusion) -- Reviewer 2
pdf, 430kb
Contact: emlsecretariat@who.int
Medicine Access and Rational Use (MAR)
20 Avenue Appia
CH-1211 Geneva 27